Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Clinical studies on SY5555 in pediatrics]

T Sekiguchi1, T Okamoto

  • 1Department of Pediatrics, Takamatsu Red Cross Hospital.

The Japanese Journal of Antibiotics
|February 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A novel ubiquinone reductase activity in rat cytosol.

FEBS letters·1992
Same author

[Clinical studies on cefprozil in pediatrics].

The Japanese journal of antibiotics·1992
Same author

Reduction of the effluent volume in high-output ileostomy patients by a somatostatin analogue, SMS 201-995.

International journal of colorectal disease·1992
Same author

Risk factors associated with postoperative persistent hypertension in patients with primary aldosteronism.

Surgery·1992
Same author

[Effects of magnesium and calcium on muscle contractility and neuromuscular blockade produced by muscle relaxants and aminoglycoside].

Masui. The Japanese journal of anesthesiology·1992
Same author

Gastric volvulus complicating myotonic dystrophy.

Hepato-gastroenterology·1992

This study found SY5555 effective for treating bacterial infections in children. The antibiotic showed good to excellent clinical responses in all patients, eradicating most causative organisms.

Area of Science:

  • Pediatric infectious diseases
  • Bacteriology
  • Clinical pharmacology

Background:

  • Acute bacterial infections pose a significant health challenge in pediatric populations.
  • Effective antibiotic therapy is crucial for managing pediatric bacterial infections and preventing complications.

Observation:

  • SY5555, administered orally in dry syrup or tablet form, was given to 21 children with various acute bacterial infections.
  • Infections included pharyngitis, tonsillitis, bronchitis, gastroenteritis, scarlet fever, lymphadenitis, and urinary tract infections.

Findings:

  • All 21 pediatric patients achieved good to excellent clinical responses.
  • Of 11 identified causative bacterial strains, 8 were eradicated, and 3 showed decreased counts.
  • Minor adverse events included loose stools in 3 cases and eosinophilia in 1 case.

Related Experiment Videos

Implications:

  • SY5555 demonstrates significant efficacy and tolerability as an antibiotic treatment for pediatric bacterial infections.
  • These findings support the use of SY5555 in clinical practice for treating a range of bacterial infections in children.
  • Further research could explore SY5555's efficacy against a broader spectrum of pediatric bacterial pathogens.